Clinical trial
A Long-term Follow-up Study to Evaluate the Safety of RGX-111
NCT06103487 is registered in ClinicalTrials.gov with REGENXBIO Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-term Follow-up Study to Evaluate the Safety of RGX-111
- Lead sponsor
- REGENXBIO Inc.
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- July 24, 2023
- Completion date
- September 30, 2027
- Enrollment
- 21 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.